Balchem Corporation is a high-quality specialty chemicals business — a perfect Piotroski score of 9 out of 9, a moat score of 7.0, and best-in-class margins — with a consistent earnings delivery record, but the stock screens expensive at a forward multiple of 26.8 times and offers only 4.3% headroom to the take-profit target, leaving the risk/reward insufficient to justify a new position at current levels.
Thesis pillars
- Expensive Valuation Screens↑Improving
- High Quality Piotroski Perfect Score→Stable
- Consistent Earnings Delivery→Stable
- +1 more pillar — see the Why tab for full reasoning
Balchem Corporation (BCPC) Stock Analysis
Basic Materials · Specialty Chemicals
Hold if already holding. Not a fresh buy at $171.61, but acceptable to hold if already in. Reasons: Thin upside margin: 3.6%; Sector modifier (Basic Materials): -0.1.
We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that... Read more
Hold if already holding. Not a fresh buy at $171.61, but acceptable to hold if already in. Reasons: Thin upside margin: 3.6%; Sector modifier (Basic Materials): -0.1. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.7/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 44d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-09-05Recent Developments — Balchem Corporation
Latest news
- NEWS Balchem Corp (BCPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey — TradingKey neutral
- NEWS Balchem Corp (BCPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com — tradingkey.com neutral
- NEWS Balchem Corp (BCPC) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS BCPC|Balchem Corp|Price:162.040|Chg%:-1.670 - TradingKey — TradingKey neutral
- NEWS Balchem (BCPC) Q3 2025 Earnings Report - Results, Call & Slides - TipRanks — TipRanks neutral
Generated 2026-09-05T22:02:19Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $171.61, but acceptable to hold if already in. Reasons: Thin upside margin: 3.6%; Sector modifier (Basic Materials): -0.1. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $177.86 (+3.6%), stop $164.90 (−4.1%), A.R:R 0.7:1. Score 5.7/10, moderate confidence.
Take-profit target: $177.86 (+3.6% upside). Target $177.86 (+3.6%), stop $164.90 (−4.1%), A.R:R 0.7:1. Stop-loss: $164.90.
Thin upside margin: 3.6%; Sector modifier (Basic Materials): -0.1; Negative momentum.
Balchem Corporation trades at a P/E of 33.8 (forward 27.4). TrendMatrix value score: 4.0/10. Verdict: Hold.
9 analysts cover BCPC with a consensus score of 4.0/5. Average price target: $209.
What does Balchem Corporation do?We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional,...
We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that offer products and services to different markets: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.